SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Rosetta Inpharmatics (RSTA)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dan Spillane who wrote (16)12/3/2000 1:30:29 PM
From: tuck   of 31
 
Looking at this puppy for bioinformatics section of Trickle portfolio. One thing I like about it in real life is the following from the Pacific Exchange:

"Rosetta Inpharmatics options will trade on the January expiration cycle. Position and exercise limits have been set at 22,500 contracts. RRQ options have been allocated to lead market maker George Stone of BOTTA Capital Management."

Trickle buys shares, but I like to enter via sold puts and hedge with calls at times. Always nice to know the name of the guy wiggling the bid on me.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News